OLOMOUCINE

SynDRA canonical compound SYN0000753 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	CDK1
Mechanism of action	CDK inhibitor

All known targets

CDK1
CDK2
CDK5
MAPK1

Mechanisms of action (all sources)

cyclin-dependent kinase inhibitor
CDK1 BINDER
CDK2 INHIBITOR
CDK5 INHIBITOR

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CCNA1
CCNA2
CCNB1
CCNB2
CCNB3
CCNE1
CCNE2
CDK5R1
CP1A2
CP2D6

Drug classes

Enzyme Inhibitors

Cross-references

PubChem CID: 4592
ChEMBL: CHEMBL280074
DrugBank: DB02116
ChEBI: 44661
PDB: OLO
TTD: D00BPA
LINCS BRD: BRD-K82731415

Synonyms

4erk
UNII-6A839B2HYS
2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine
6A839B2HYS
CHEMBL280074
2-{[6-(benzylamino)-9-methyl-9h-purin-2-yl]amino}ethanol
6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine
6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine
Ethanol,2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
OLO
2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine
6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine
Olomucine
NSC 666096
2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine
2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol
CHEBI:44661
2-((6-(benzylamino)-9-methyl-9H-purin-2-yl)amino)ethan-1-ol
RefChem:856758
DTXCID8066559
2-((6-(Benzylamino)-9-methyl-9H-purin-2-yl)amino)ethanol
MFCD00189360
6-benzylamino-2-[2-hydroxyethylamino]-9-methylpurine
2-(2-Hydroxyethylamino)-6-benzylamino-9-isopropylpurine
SR-01000075518
2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol
Olomoucine?
purine deriv. 5
Kinome_2870
Tocris-1284
1w0x
BiomolKI_000046
Lopac-O-0886
BiomolKI2_000052
UPCMLD-DP136
CBiol_002050
Lopac0_000883

Look up OLOMOUCINE in the interactive SynDRA portal →